Episode 136 | FIB-4 and Metabolic Liver Disease

Your AST and ALT can be completely normal while liver fibrosis is quietly developing. In this episode of *The Health Pulse*, we explore one of the biggest blind spots in routine liver testing and explain why **FIB-4** can provide important information that a standard liver panel may miss. We begin with **metabolic dysfunction-associated steatotic liver disease (MASLD)**, the condition formerly known as NAFLD. Closely connected to insulin resistance, visceral fat, prediabetes, and type 2 diabetes, MASLD can progress silently from excess liver fat to inflammation and eventually **fibrosis—the accumulation of scar tissue that ultimately determines much of the long-term risk of cirrhosis and liver-related complications**. We break down the metabolic biology behind that progression, including **de novo lipogenesis**, where excess energy—particularly from carbohydrates and fructose—can be converted into fat inside the liver. As metabolic dysfunction progresses, lipotoxicity, oxidative stress, and inflammation can push simple steatosis toward **MASH** and eventually fibrosis. Then we address the problem with relying on liver enzymes alone. **AST and ALT primarily reflect cellular injury; they do not directly measure fibrosis.** Someone can therefore have clinically important liver disease without dramatically elevated enzymes, making a row of green check marks on a laboratory portal potentially misleading. That's where the **FIB-4 index** becomes useful. Using only **age, AST, ALT, and platelet count**, FIB-4 provides a noninvasive first-line estimate of the likelihood of advanced liver fibrosis. We explain the commonly used low-, intermediate-, and high-risk thresholds, why age changes interpretation, and how platelet counts and the relationship between AST and ALT can provide clues about advancing disease. An abnormal FIB-4 isn't a diagnosis. Instead, it can identify people who may benefit from further evaluation with tools such as **transient elastography (FibroScan)** or the **Enhanced Liver Fibrosis (ELF) test**. Finally, we discuss what can change the trajectory. Weight reduction when appropriate, resistance and aerobic exercise, improved insulin sensitivity, and nutritional strategies can substantially reduce liver fat and metabolic stress. We also look at the evolving treatment landscape, including medications such as **resmetirom and semaglutide for appropriately selected patients with MASH and fibrosis**. And because MASLD rarely exists in isolation, we connect liver health back to cardiovascular risk through **ApoB and the broader metabolic picture**. If your annual physical says your liver enzymes are "normal," this episode explains why that shouldn't always be the end of the conversation—and how information already sitting inside routine bloodwork may help identify fibrosis risk earlier. 📞 **Need lab work done from the comfort of home?** QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 **Book your appointment or learn more at:** 👉 Quick Lab Mobile 📧 **Contact us:** info@quicklabmobile.com 💬 **Enjoyed the episode?** Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.  **Disclaimer:** The information provided in this podcast is for **informational purposes only** and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it **does not replace professional medical consultation, diagnosis, or treatment**. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a **medical emergency**, such as severe pain, difficulty breathing, or other urgent symptoms, call **your local emergency services** immediately. By listening to this podcast, you acknowledge that **The Health Pulse** and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.